Works matching IS 13657852 AND DT 2012 AND VI 15 AND IP 4

Results: 16

Does variation in either age at start of therapy or duration of therapy make chemoprevention with finasteride cost-effective?

Published in:

Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 4, p. 380, doi. 10.1038/pcan.2012.26

By:

Stewart, S B;
Scales, C D;
Moul, J W;
Reed, S D

Publication type:

Article

AST-induced bone loss in men with prostate cancer: exercise as a potential countermeasure.

Published in:

Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 4, p. 329, doi. 10.1038/pcan.2012.22

By:

Bolam, K A;
Galvão, D A;
Spry, N;
Newton, R U;
Taaffe, D R

Publication type:

Article

Identification of genetic risk associated with prostate cancer using ancestry informative markers.

Published in:

Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 4, p. 359, doi. 10.1038/pcan.2012.19

By:

Ricks-Santi, L J;
Apprey, V;
Mason, T;
Wilson, B;
Abbas, M;
Hernandez, W;
Hooker, S;
Doura, M;
Bonney, G;
Dunston, G;
Kittles, R;
Ahaghotu, C

Publication type:

Article

MicroRNAs in prostate cancer: from biomarkers to molecularly-based therapeutics.

Published in:

Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 4, p. 314, doi. 10.1038/pcan.2012.3

By:

Gordanpour, A;
Nam, R K;
Sugar, L;
Seth, A

Publication type:

Article

Analysis of prostate cancer association with four single-nucleotide polymorphisms from genome-wide studies and serum phyto-estrogen concentrations.

Published in:

Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 4, p. 365, doi. 10.1038/pcan.2012.24

By:

Ho, C K M;
Halley, L;
Wei, J;
Habib, F K

Publication type:

Article

Transcriptional repression of RUNX2 is associated with aggressive clinicopathological outcomes, whereas nuclear location of the protein is related to metastasis in prostate cancer.

Published in:

Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 4, p. 369, doi. 10.1038/pcan.2012.31

By:

Yun, S J;
Yoon, H-Y;
Bae, S-C;
Lee, O-J;
Choi, Y-H;
Moon, S-K;
Kim, I Y;
Kim, W-J

Publication type:

Article

Editor's Comments.

Published in:

Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 4, p. 313, doi. 10.1038/pcan.2012.43

By:

Freedland, S J

Publication type:

Article

Variants in the HEPSIN gene are associated with susceptibility to prostate cancer.

Published in:

Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 4, p. 353, doi. 10.1038/pcan.2012.17

By:

Kim, H J;
Han, J H;
Chang, I H;
Kim, W;
Myung, S C

Publication type:

Article

The prevalence of lower urinary tract symptoms and treatment-seeking behaviour in males over 40 years in Singapore: a community-based study.

Published in:

Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 4, p. 402, doi. 10.1038/pcan.2012.35

By:

Chong, C;
Fong, L;
Lai, R;
Lau, W K O;
Hartmann, M;
Chia, S E

Publication type:

Article

Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram.

Published in:

Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 4, p. 374, doi. 10.1038/pcan.2012.21

By:

Kutikov, A;
Cooperberg, M R;
Paciorek, A T;
Uzzo, R G;
Carroll, P R;
Boorjian, S A

Publication type:

Article

Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer.

Published in:

Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 4, p. 339, doi. 10.1038/pcan.2012.14

By:

Fukuma, Y;
Matsui, H;
Koike, H;
Sekine, Y;
Shechter, I;
Ohtake, N;
Nakata, S;
Ito, K;
Suzuki, K

Publication type:

Article

Low serum neutrophil count predicts a positive prostate biopsy.

Published in:

Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 4, p. 386, doi. 10.1038/pcan.2012.27

By:

Fujita, K;
Imamura, R;
Tanigawa, G;
Nakagawa, M;
Hayashi, T;
Kishimoto, N;
Hosomi, M;
Yamaguchi, S

Publication type:

Article

Safety and effectiveness of neoadjuvant luteinizing hormone-releasing hormone agonist plus low-dose estramustine phosphate in high-risk prostate cancer: a prospective single-arm study.

Published in:

Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 4, p. 397, doi. 10.1038/pcan.2012.29

By:

Koie, T;
Ohyama, C;
Yamamoto, H;
Hatakeyama, S;
Yoneyama, T;
Hashimoto, Y;
Kamimura, N

Publication type:

Article

The impact of county-level radiation oncologist density on prostate cancer mortality in the United States.

Published in:

Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 4, p. 391, doi. 10.1038/pcan.2012.28

By:

Aneja, S;
Yu, J B

Publication type:

Article

Growth/differentiation factor-15: prostate cancer suppressor or promoter?

Published in:

Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 4, p. 320, doi. 10.1038/pcan.2012.6

By:

Vaňhara, P;
Hampl, A;
Kozubík, A;
Souček, K

Publication type:

Article

Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer.

Published in:

Prostate Cancer & Prostatic Diseases, 2012, v. 15, n. 4, p. 346, doi. 10.1038/pcan.2012.16

By:

Colquhoun, A J;
Venier, N A;
Vandersluis, A D;
Besla, R;
Sugar, L M;
Kiss, A;
Fleshner, N E;
Pollak, M;
Klotz, L H;
Venkateswaran, V

Publication type:

Article